Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and
Michael Winn1, Rebecca J M Goss, Ken-ichi Kimura
1School of Chemistry, University of East Anglia, Norwich, NR4 7TJ, UK.
Natural Product Reports
|January 30, 2010
Summary
New antibiotics targeting Gram-negative bacteria are urgently needed. This review covers nucleoside natural products that inhibit MraY, a key enzyme in bacterial cell wall synthesis, and discusses biosynthetic studies.
Area of Science:
- Microbiology
- Natural Products Chemistry
- Drug Discovery
Background:
- The urgent need for novel antibiotics, particularly against Gram-negative bacteria, is highlighted due to a scarcity of new drugs in recent decades.
- Existing antibiotics have limited structural diversity, with only four new classes introduced in the past 40 years.
- Bacterial translocase MraY, crucial for peptidoglycan biosynthesis, and fungal chitin synthase are identified as key targets for nucleoside natural product antibiotics.
Purpose of the Study:
- To review the current landscape of antibiotic development, focusing on challenges in targeting Gram-negative pathogens.
- To explore the role of nucleoside natural products as potential therapeutic agents.
- To summarize biosynthetic studies on important families of nucleoside antibiotics.
Main Methods:
- Literature review of scientific publications on antibiotic discovery, bacterial cell wall biosynthesis, and natural product chemistry.
- Analysis of existing data on nucleoside natural product antibiotics targeting MraY and chitin synthase.
- Compilation and discussion of biosynthetic pathways for nikkomycin, caprazamycin, and pacidamycin/mureidomycin families.
Main Results:
- Nucleoside natural products represent a promising class of compounds with potential against challenging bacterial infections.
- MraY and chitin synthase are validated targets for these agents, offering avenues for novel drug development.
- Review of biosynthetic studies provides insights into the production and potential modification of these valuable natural products.
Conclusions:
- Continued research into nucleoside natural products is essential for developing new antibiotics to combat antimicrobial resistance.
- Understanding the biosynthesis of these compounds can facilitate the development of semi-synthetic derivatives with improved efficacy.
- Targeting essential bacterial pathways like peptidoglycan synthesis remains a critical strategy in the fight against Gram-negative infections.
More Related Videos
Related Concept Videos
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Biosynthesis of Polysaccharides
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...


